Results 131 to 140 of about 2,157 (194)
SCID newborn screening: seven-year performance and outcomes including T-cell lymphopenia in Catalonia (Spain). [PDF]
Front ImmunolArgudo-Ramírez A, Martín-Nalda A, Laguna J, Riviere JG, González de Aledo-Castillo JM, López-Galera RM, Colobran R, Batlle-Masó L, Quintero Y, Martínez C, Paredes-Fuentes AJ, Perurena-Prieto J, Alonso L, Prats-Viedma B, García-Villoria J, Soler-Palacín P. +15 moreeuropepmc +1 more sourcePredicting disease progression in multiple sclerosis with clinically accessible information and technology. [PDF]
J NeurolFuchs TAN, Schoonheim MM, Strijbis EMM, Jelgerhuis JR, Horakova D, Havrdova EK, Uher T, Zivadinov R, Ozakbas S, Girard M, Alroughani R, Grammond P, Lugaresi A, Tomassini V, Kalincik T, Roos I, Gerlach O, van der Walt A, Khoury SJ, van Pesch V, Surcinelli A, Foschi M, Sa MJ, D'amico E, Kuhle J, Cartechini E, Maimone D, Karabudak R, Soysal A, Spitaleri D, Laureys G, Taylor B, D'hooghe M, Ampapa R, Castillo-Triviño T, Altintas A, Gray O, Gouider R, Meca-Lallana JE, Kermode AG, Fabis-Pedrini M, Carroll WM, de Gans K, Sanchez-Menoyo JL, Etemadifar M, Al-Asmi A, McCombe P, Simu M, Yetkin MF, Al-Harbi T, Csepany T, Lalive P, Hardy TA, Ramanathan S, Willekens B, Sempere AP, Cárdenas-Robledo S, Habek M, Singhal B, Grigoriadis N, Simo M, Shaygannejad V, Blanco Y, Aguera-Morales E, Garber J, Solaro C, Shuey N, Khurana D, Decoo D, Moghadasi AN, Buzzard K, Skibina O, John N, Petersen T, Weinstock-Guttman B. +74 moreeuropepmc +1 more sourceSystemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection. [PDF]
Sci RepNuber-Champier A, Breville G, Voruz P, Jacot de Alcântara I, Cionca A, Allali G, Lalive PH, Benzakour L, Lövblad KO, Braillard O, Nehme M, Coen M, Serratrice J, Reny JL, Pugin J, Guessous I, Landis BN, Assal F, Péron JA. +18 moreeuropepmc +1 more sourcePersonalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study. [PDF]
Mult SclerYaldizli Ö, Benkert P, Achtnichts L, Bar-Or A, Bohner-Lang V, Bridel C, Comabella M, Findling O, Disanto G, Finkener S, Gobbi C, Granziera C, Herwerth M, Hoepner R, Horakova D, Kamber N, Khalil M, Kunz P, Lalive P, Linker R, Lorscheider J, Müller S, Oechtering J, Pettypool V, Piehl F, Pot C, Roth P, Théaudin M, Tintore M, Tur C, Uffer D, Uginet M, Vehoff J, Wiendl H, Ziemssen T, Zecca C, Salmen A, Leppert D, Derfuss T, Derfuss T, Kappos L, Hemkens LG, Janiaud P, Kuhle J. +43 moreeuropepmc +1 more sourceAberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. [PDF]
Neurol Neuroimmunol NeuroinflammOechtering J, Schaedelin SA, Stein K, Maleska Maceski A, Melie-Garcia L, Benkert P, Cagol A, Leber S, Galbusera R, Ruberte E, Hu W, Qureshi F, Orleth A, Demuth L, Willemse E, Heijnen I, Regeniter A, Derfuss TJ, Fischer-Barnicol B, Achtnichts L, Mueller S, Hoepner R, Lalive PH, Bridel C, D'Souza M, Pot C, Du Pasquier RA, Gobbi C, Zecca C, Wiendl H, Lieb JM, Lamers C, Kappos L, Trendelenburg M, Leppert D, Granziera C, Kuhle J, Lünemann JD, and the Swiss MS Cohort Study. +38 moreeuropepmc +1 more sourceContrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort. [PDF]
Bioengineering (Basel)Greselin M, Lu PJ, Melie-Garcia L, Ocampo-Pineda M, Galbusera R, Cagol A, Weigel M, de Oliveira Siebenborn N, Ruberte E, Benkert P, Müller S, Finkener S, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb JM, Diepers M, Wagner F, Vargas MI, Pasquier RD, Lalive PH, Pravatà E, Weber J, Gobbi C, Leppert D, Kim OC, Cattin PC, Hoepner R, Roth P, Kappos L, Kuhle J, Granziera C. +37 moreeuropepmc +1 more sourceSerum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis. [PDF]
Ann NeurolBenkert P, Maleska Maceski A, Schaedelin S, Oechtering J, Zadic A, Vilchez Gomez JF, Melie-Garcia L, Cagol A, Galbusera R, Subramaniam S, Lorscheider J, Galli E, Mueller J, Fischer-Barnicol B, Achtnichts L, Findling O, Lalive PH, Bridel C, Uginet M, Müller S, Pot C, Mathias A, Du Pasquier R, Salmen A, Hoepner R, Chan A, Disanto G, Zecca C, D'Souza M, Hemkens LG, Yaldizli Ö, Derfuss T, Roth P, Gobbi C, Brassat D, Tackenberg B, Pedotti R, Raposo C, Oksenberg J, Wiendl H, Berger K, Hermesdorf M, Piehl F, Conen D, Buser A, Kappos L, Khalil M, Granziera C, Abdelhak A, Leppert D, Willemse EAJ, Kuhle J, Swiss MS Cohort study (SMSC). +52 moreeuropepmc +1 more sourceTreatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. [PDF]
Mult Scler J Exp Transl ClinDisanto G, Schaedelin S, Oechtering J, Lorscheider J, Galbusera R, Finkener S, Achtnichts L, Lalive P, Müller S, Pot C, Hoepner R, Salmen A, Zecca C, Hemkens LG, D'Souza M, Fischer-Barnicol B, Du Pasquier R, Roth P, Yaldizli Ö, Einsiedler M, Derfuss T, Derfuss T, Kappos L, Gobbi C, Granziera C, Uginet M, Maceski AM, McDonald K, Leppert D, Benkert P, Kuhle J, Swiss MS Cohort Study. +31 moreeuropepmc +1 more source
